Sutherlandia frutescens (L.) R. Br. (Fabaceae): Cancer bush;Sutherlandia frutescens (L.) R. Br. (Fabaceae): Baguenaudier d'Éthiopie

Phytotherapie

Volumn 12, Issue 3, 2014, Pages 184-188

  Abdou, P N ^a   Goetz, P ^a   Ghedira, K ^b  

^a Diplômé du DU de Phytothérapie de Paris XIII La Grande Blanchère ^*  (France)

^b UNIVERSITY OF MONASTIR   (Tunisia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; FABACEAE; NONHUMAN; SUTHERLANDIA FRUTESCENS;

EID: 84904727721     PISSN: 16248597     EISSN: 17652847     Source Type: Journal    
DOI: 10.1007/s10298-014-0866-2     Document Type: Article

References (32)

1. Itis (Integrated taxonomic information system): Fabaceae of North America Update database (version 2011); (updated for ITIS by the Flora of North America Expertise Network, in connection with an update for USDA PLANTS (2007-2010): http://www.itis.gov/servlet/SingleRpt/SingleRpt
2. Phillips E, Dyer RA (1989) Revista Sudamer. Bot. 1: 76, fig. 2 (1934). - Lock, Leg. Afr. Check-list: 265
3. Exotic-plants: http://www.exotic-plants.de/graines/graines-Afrique-du- Sud/Sutherlandia-frutescens.php
4. Blueskyorganics: http://www.blueskyorganics.co.za/?spa-products=70-olive- leaf-tea-with-30-sutherlandia-cancer-bush
5. Pousset JL (2004) Plantes médicinales d 'Afrique. Comment les reconnaître et les utiliser. Ed. Édisud, La Calade, France
6. Roberts M (1990) Indigenous healing plants. Southern Book Publishers, Halfway House, Gauteng, South Africa, 55
7. Fu X, Li XC, Smilie TJ, Khan IA, et al. (2008) Cycloartane glcosides from Sutherlandia frutescens . J Nat Prod 71: 1749- 53
8. Fu X, Li XC, Avula B, IA Khan IA, et al. (2009) Flavonoid glycosides from Sutherlanida frutescens. Planta Med 75: 34
9. Gericke N, Albrecht CF, Van Wyk B, et al. (2001) Sutherlandia frutescens. AJMH 13: 9-15
10. Shaik S, Singh N, Nicholas A (2011) A comparison of the selected secondary metabolites content present in the cancer-bush Lessertia (Sutherlandia) frutescens L. extracts. Afr J Tradit Complement Altern Med 8: 429-34
11. Tai J, Cheung S, Chan E, Hasman D (2004) In vitro culture studies of Sutherlandia frutescens on human tumor cell lines. J Ethnopharmacol 93: 9-19 (Pubitemid 38739263)
12. Van Wyk BE, Albrecht C (2008) A review of the taxonomy, ethnobotany, chemistry and pharmacology of Sutherlandia frutescens (Fabaceae). J Ethnopharmacol 119: 620-9
13. Zhang B, Leung WK, Zou Y, Paulsen BS (2014) Immunomodulating polysaccharides from Lessertia frutescens leaves: Isolation, characterization and structure activity relationship. J Ethnopharmacol 152: 340-8
14. Ojewole JA (2004) Analgesic, anti-inflammatory and hypoglycemic effects of Sutherlandia frutescens R. Br. Variety Incana E. Mey) shoot aqueous extract. Methods Find Exp Clin Pharmacol 26: 409-16
15. Van Wyk B, Gericke N (2000) People's plants - a guide to the useful plants in South Africa. Pretoria, Briza
16. Sivakumar S, Palsamy P, Subramanian SP (2010) Impact of D-pinitol on the attenuation of proinflammatory cytokines, hyperglycemia-mediated oxidative stress and protection of kidney tissue ultrastructure in streptozotocin-induced diabetic rats. Chem Biol Interact 188: 237-45
17. Capasso R, Izzo AA, Pinto L, et al. (2000) Phytotherapy and quality of herbal medicines. Fitoterapia 71: S58-S65 (Pubitemid 30621696)
18. Ostlund RE, Sherman WR (1996) Pinitol and derivatives thereof for the treatment of metabolic disorders. US Patent 5, 8827,896
19. Chadwick WA, Roux S, van de Venter M, et al. (2007) Anti-diabetic effects of Sutherlandia frutescens in Wistar rats fed a diabetogenic diet. J Ethnopharmacol 109: 121-7 (Pubitemid 44822651)
20. Narayanan Joshi DD, Mujumdar AM (1987) Pinitol - a new antidiabetic compound from the leaves of Bougainvillea spectabilis . Current Sci 56: 139-41
21. Fernandes AC, Cromarty AD, Albrecht C, van Rensburg CE (2004) The antioxidant potential of Sutherlandia frutescens. J Ethnopharmacol 95: 1-5 (Pubitemid 39221403)
22. Ngcobo M, Gqaleni N, Chelule PK, et al. (2012) Effects of Sutherlandia frutescens extracts on normal T-lymphocytes in vitro. Afr J Tradit Complement Altern Med 9: 73-80
23. Chinkwo KA (2005) Sutherlandia frutescens extracts can induce apoptosis in cultured carcinoma cells. J Ethnopharmacol 98: 163-70
24. Skerman NB, Joubert AM, Cronjé MJ (2011) The apoptosis inducing effects of Sutherlandia ssp. extracts on an oesophageal cancer cell line. J Ethnopharmacol 137: 1250-60
25. Swaffer DS, Ang CY, Desai PB, Rosenthal GA (1994) Inhibition of the growth of human pancreatic cancer cells by the arginine antimetabolite L-canavanine. Cancer Res 54: 6045-8 (Pubitemid 24378625)
26. Grandi M, Roselli L, Vernay M (2005) Lessertia (Sutherlandia frutescens) et la fatigue en cancérologie. Phytothérapie 3: 110-13 (Pubitemid 41124513)
27. Harnett SM, Oosthuizen V, van de Venter M (2005) Anti-HIV activities of organic and aqueous extract of Sutherlandia frutescens and Lobostemon trigonous. J Ethnopharmacol 96: 113-9 (Pubitemid 39575039)
28. Smith A (1895) A contribution to the South African materia medica, 3rd ed. Lovedale, South Africa
29. Mills EJ, Foster BC, van Heeswijk RP, et al. (2005) Impact of African herbal medicines on antiretroviral metabolism. AIDS 19:95-7 (Pubitemid 40111025)
30. Seier JV, Mdhuli M, Dhansay MA, et al. (2002) A toxicity study of Sutherlandia leaf powder (Sutherlandia microphylla) consumption. South African Ministry of Health Document
31. Prete P (1985) Effects of L-canavanine on immune function in normal and autoimmune mice: disordered B-cell function by a dietary amino acid in the immunoregulaion of autoimmune disease. Can J Physiol Pharmacol 63: 843-54
32. Dalvi S (2003) Sutherlandia for immune support. Positive Health 23-5